Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer - Ultra-HART


Condition: Prostate Cancer, Adaptive Radiotherapy, Quality of Life

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT06355050

Sponsor: Jena University Hospital

Phase:

Eligibility:

  • Age: minimum 18 Years maximum 120 Years
  • Gender: Male

Inclusion Criteria:

  • no androgen deprivation therapy within the last 2 months prior to RT
  • good performance status (Eastern Cooperative Oncology Group, ECOG, 0/1)
  • no secondary malignancy

View trial on ClinicalTrials.gov